ARYA Sciences Acquisition Corp IV

ARYA Sciences Acquisition Corp IV (Nasdaq: ARYD) is a blank-check company sponsored by ARYA Sciences, the life sciences SPAC vehicle affiliated with Perceptive Advisors, a healthcare-focused investment firm. The company completed its initial public offering in 2021 and targets acquisition opportunities in the life sciences and biotechnology sector. ARYD filed an amended quarterly report, Form 10-Q/A, with the SEC on May 21, 2024, under accession number 0001140361-24-026933, reflecting an update to previously reported financial information while the company continued its search for a business combination target. Sign up at SpacDesk for full filing history, deal timelines, and sponsor analytics on ARYD and hundreds of other active and historical SPACs.